Today: 19 July 2026
Browse Category

NYSE:RHHBY 17 July 2025 - 16 September 2025

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly’s forthcoming Richmond-area factory is set to be one of the largest and most advanced pharmaceutical manufacturing sites in the world. At a cost of $5 billion, Lilly will construct a high-tech production campus in Goochland County’s West Creek Business Park, a site that had been prepped for a previous project and now deemed “the perfect spot” for fast construction Washingtonpost. The facility’s core mission: make more of the critical drug ingredients that Lilly usually sources overseas, right here on U.S. soil Washingtonpost Washingtonpost.
16 September 2025
·······
Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Sources: Key news and expert quotes were gathered from Fierce Biotech fiercebiotech.com fiercebiotech.com, Fierce Pharma fiercepharma.com fiercepharma.com, Fierce Healthcare fiercehealthcare.com fiercehealthcare.com, STAT News statnews.com statnews.com, the Florida Phoenix floridaphoenix.com floridaphoenix.com, CIDRAP cidrap.umn.edu cidrap.umn.edu, and other authoritative sources as cited above. Each development is linked to its original reporting for further reading. The roundup covers events and announcements from August 18–19, 2025, providing a comprehensive digest of the latest in biotech, pharma, medical, and health news.
19 August 2025
····
AI Pathology Breakthrough: Roche’s Lung Cancer Diagnostic Makes FDA History

AI Pathology Breakthrough: Roche’s Lung Cancer Diagnostic Makes FDA History

In a milestone for artificial intelligence in medicine, Roche’s VENTANA TROP2 RxDx test has become the first AI-powered diagnostic to receive the FDA’s coveted Breakthrough Device Designation Roche Clpmag. This computational pathology companion diagnostic – essentially a software-driven analysis of cancer biopsy images – gained the special status in April 2025 for its potential to radically improve treatment selection in non–small cell lung cancer Roche Curetoday. The FDA’s designation signals that regulators see this tool as a game-changer for patients with advanced lung cancer, and it will fast-track the test’s review and availability in clinical practice Curetoday Openaccessgovernment.
17 July 2025
·
Go toTop